BPG is committed to discovery and dissemination of knowledge
Minireviews
©The Author(s) 2025.
World J Stem Cells. Dec 26, 2025; 17(12): 111374
Published online Dec 26, 2025. doi: 10.4252/wjsc.v17.i12.111374
Table 1 Gene editing and retinal organoid strategies in retinal therapy
Strategy
Application
Current limitations
Ref.
CRISPR/Cas9 gene editingCorrection of pathogenic mutations in patient-specific iPSCsOff-target effects, ethical concerns, and delivery efficiency[26,27,30,31]
Retinal organoidsModeling retinal development and disease; source of transplantable cellsLimited maturation, variability, and scalability for clinical use[29-42]


Write to the Help Desk